| Simone L Dorsey, MS LMFT | |
|
32r Padelford St, Berkley, MA 02779-1104 | |
| (774) 231-8008 | |
| Not Available |
| Full Name | Simone L Dorsey |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 32r Padelford St, Berkley, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205580461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 1865 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Simone L Dorsey, MS LMFT 32r Padelford St, Berkley, MA 02779-1104 Ph: () - | Simone L Dorsey, MS LMFT 32r Padelford St, Berkley, MA 02779-1104 Ph: (774) 231-8008 |
News Archive
A team of neuroscientists has discovered important new information in the search for an effective treatment for Alzheimer's disease, the debilitating neurological disorder that afflicts more than 5.3 million Americans and is the sixth-leading cause of death in the United States. Hey-Kyoung Lee, associate professor in the University of Maryland Department of Biology, and her research team have shown that they may be able to eliminate debilitating side effects caused by a promising Alzheimer's drug by stimulating the brain's nicotine receptors.
Proteins sometimes run amuck. All the good stuff (the useful genetic and biological material) they contain can get distorted. Mutations in specific amino acids can cause long strands of proteins to curl in on themselves (like a ball of wool a cat has played with) and refuse to break apart.
The B3DD Summit will be held in Boston from August 13-15, 2019. This news story provides an overview of what you can expect at this year's conference.
The MRIdian (me-rid-i-an) system from ViewRay, a privately held medical device company, is now being used to treat patients at the University of Wisconsin Carbone Cancer Center in Madison, Wisconsin, the second clinical group in the world to treat patients with MRI-guided radiation therapy.
According to a latest study many medical devices recalled in recent years by the Food and Drug Administration (FDA) because they posed a high risk to patients were not rigorously studied before being approved for patient use. The study, appearing on the web site of The Archives of Internal Medicine, said that most medical devices that were the subject of high-risk recalls from 2005 to 2009 had been cleared through a regulatory pathway with little testing. This included external heart defibrillators, hospital infusion pumps and mechanical ventilators.
› Verified 6 days ago